Losartan Inhibits Cellular Uptake of Oxidized LDL by Monocyte-Macrophages from Hypercholesterolemic Patients
- 5 July 2000
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 273 (2), 417-420
- https://doi.org/10.1006/bbrc.2000.2963
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- CD36, a Novel Receptor for Oxidized Low-Density Lipoproteins, Is Highly Expressed on Lipid-Laden Macrophages in Human Atherosclerotic AortaArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Oxidized LDL Increases and Interferon-γ Decreases Expression of CD36 in Human Monocyte–Derived MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Minimally Oxidized Low-Density Lipoprotein Increases Expression of Scavenger Receptor A, CD36, and Macrosialin in Resident Mouse Peritoneal MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Angiotensin II–Modified LDL Is Taken Up by Macrophages Via the Scavenger Receptor, Leading to Cellular Cholesterol AccumulationArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.JCI Insight, 1995
- Modified forms of low density lipoprotein and atherosclerosisAtherosclerosis, 1993
- Role of oxidized low density lipoprotein in atherogenesis.JCI Insight, 1991
- The contribution of the macrophage receptor for oxidized LDL to its cellular uptakeBiochemical and Biophysical Research Communications, 1991
- Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.Circulation Research, 1991
- Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.Proceedings of the National Academy of Sciences of the United States of America, 1981